Journal: Scientific Reports
Article Title: AAV-mediated intracerebral expression of an α-synuclein-targeting intrabody improves motor functions in aged rats
doi: 10.1038/s41598-025-34908-1
Figure Lengend Snippet: NAC32 intrabody enhances synaptic marker expression and dopamine levels in the striatum of aged rats. Aged rats (18 months) received bilateral injections of AAV1-NAC32 (expressing the NAC32 intrabody; n = 6) or AAV1-mCherry (control; n = 4) into the substantia nigra. (A) Fourteen weeks post-injection, striatal tissues were harvested for Western blot analysis of synaptic markers PSD95, synaptophysin, and TH, with β-actin as a loading control. The grouped blots shown were cropped from different exposures of distinct parts of the same gel. (B , C , D) Protein levels were quantified by densitometry, normalized to β-actin, and expressed as mean ± SEM. Significant differences were determined using the Student’s t-test (* p < 0.05, ** p < 0.01). Molecular weights (kDa) of the protein markers are indicated. (E) In parallel, dopamine levels in the striatum were measured using ELISA and normalized to total protein content, determined by the BCA assay. Data are presented as mean ± SEM; * p < 0.05 indicates statistical significance (Student’s t-test).
Article Snippet: The striatum homogenates were prepared as described in the section on Western blotting analysis and were subjected to quantification of total proteins using the BCA Protein Assay Kit (#23225, Pierce), measurement of dopamine with the DA ELISA Kit (#E-EL-0046, Elabscience), and assessment of 10 inflammation-related cytokines using the Quantibody ® Rat Inflammation Array 1 (#QAR-INF-1, RayBiotech), following the manufacturer’s instructions.
Techniques: Marker, Expressing, Control, Injection, Western Blot, Enzyme-linked Immunosorbent Assay, BIA-KA